Premium
Risk Factors of Hepatocellular Carcinoma in Chronic Hepatitis C and Cirrhosis: Special Reference to Laparoscopic Findings
Author(s) -
SHIBAYAMA Takao,
MORI Shiniciro,
OHTAKE Hiroo,
HAYASHI Seishuu,
SAEKI Shunichi,
TANAKA Takahi,
TANAKA Satoshi
Publication year - 1999
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/j.1443-1661.1999.tb00187.x
Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , hepatitis c virus , gastroenterology , hepatitis c , liver disease , hepatitis , genotype , hepatitis b virus , virus , immunology , biology , gene , biochemistry
It remains unclear whether the hepatitis C virus genotype is associated with the severity and outcome of HCV‐related liver disease. The aim of this study was to determine whether hepatitis C virus genotype influenced the risk of developing hepatocelMar carcinoma. Two hundred and sixty nine patients who had chronic hepatitis C and cirrhosis without hepatocellular carcinoma were studied. The stage and activity of hepatitis were determined at laparoscopy and patients were followed up until the development of hepatocellular carcinoma or for a maximum of 16 years. Hepatitis C virus genotypes were determined by a genotyping enzyme‐linked immunosorbent assay. A cross‐sectional study revealed that the prevalence of hepatitis C virus genotype 1 increased and that of genotype 2 decreased with the progression of liver disease (pc 0.01). A follow‐up study using the Kaplan‐Meier method showed that hepatocellular carcinoma occurred more frequently in patients with hepatitis C virus genotype 1 (p<0.01), patients with a more advanced disease stage (p<0.01), and patients with reddish markings (p<0.05). Cox multivariate proportional hazards analysis confirmed that these three risk factors were independent. Hepatocellular carcinoma developed more frequently in patients with hepatitis C virus genotype 1 and pre‐cirrhosis (stage 3 chronic hepatitis with nodules) or liver cirrhosis, in whom hepatitis showed continued activity and progression. (Dig Endosc 1999; 11: 24–31)